Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3825318 | Progrès en Urologie | 2012 | 21 Pages |
Abstract
Consequences of the treatment on male fertility should be part of the information of patients with prostate cancer and their partners. The choice of treatment must take into account the desire of paternity of the couple. A semen analysis with sperm cryopreservation before any therapy should be routinely offered in men with prostate cancer, particularly among men under 55, with a partner under 43 years old or without children. If the desire for parenthood among couples, sperm cryopreservation before treatment and medical assisted reproduction are recommended.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
M.-H. Colson, E. Lechevallier, J.-J. Rambeaud, J.-C. Alimi, A. Faix, G. Gravis, J.-M. Hannoun-Levi, H. Quintens, X. Rébillard, S. Droupy,